Weekly paclitaxel and high-dose 5-Fluorouracil plus leucovorin (T-HDFL) in hormone-refractory prostate cancer: in Vitro combined effects and phase II trial

Lin, Chia-ChiChia-ChiLinHsu, Chih-HungChih-HungHsuHour, Tzyh-ChyuanTzyh-ChyuanHourCheng, Ann-LiiAnn-LiiChengHuang, Chao-YuanChao-YuanHuangHuang, Kuo-HowKuo-HowHuangChen, JunJunChenPu, Yeong-ShiauYeong-ShiauPu2010-09-032018-07-112010-09-032018-07-112007-05http://ntur.lib.ntu.edu.tw//handle/246246/199014en-US[SDGs]SDG3Weekly paclitaxel and high-dose 5-Fluorouracil plus leucovorin (T-HDFL) in hormone-refractory prostate cancer: in Vitro combined effects and phase II trial